Patents Examined by Qiuwen Mi
  • Methods to reduce fat accumulation and oxidative damage in liver using green mango extracts and compounds obtained therefrom
    Patent number: 10918683
    Abstract: Provided is a method for reducing fat accumulation in and oxidative damage to liver cells by using a green mango extract. Also provided is a method for reducing fat accumulation in liver cells by using compounds of hydrolyzable tannins isolated from the green mango extract.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: February 16, 2021
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Chin-Hsiu Yu, Shan-Yu Lin
  • Topical skin care composition
    Patent number: 10912753
    Abstract: A topical skin care composition for rejuvenation of the skin containing tetracaine, purified water, stearic acid, lauramide diethanolamine, beeswax, propylene glycol, sodium tetraborate, sodium lauryl sulfate, benzyl alcohol, glycerin, diazolidinyl urea, triethanolamine, methyl salicylate, and eucalyptus oil. The topical skin care composition of the invention is useful in the healing of the skin and in particular, after the skin has been exfoliated.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: February 9, 2021
    Inventor: Bruce Wayne Miller
  • Enhancer for catechin uptake in enterocytes
    Patent number: 10912809
    Abstract: The present invention relates to an enhancer for catechin uptake enhancer in enterocytes, wherein, by mixing a green tea extract containing catechin as an active ingredient, a Dendropanax morbifera extract, and an onion extract at a proper ratio, the stability in the digestive organ can be improved and, eventually, the catechin uptake in enterocytes can be enhanced.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: February 9, 2021
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Su Kyung Kim, Jin Oh Chung, Wan Gi Kim, Jeong Kee Kim, Song Seok Shin, Soon Mi Shim, Da Yeon Lee, Sang Ryun Yim, Eun Hye Choi
  • Murill extracts, methods for inhibiting legumain using the same, and methods for treating tumors using the same
    Patent number: 10905728
    Abstract: Extracts of Agaricus blazei Murill have been found to have anti-tumor activity. In particular, a polar, high molecular weight fraction of an Agaricus blazei Murill extract has been found which has an inhibitory effect on legumain activity. Extracts of Agaricus blazei Murill can be used in a pharmaceutical composition to inhibit cysteine protease legumain in a patient suffering from a tumor thereby treating the tumor and preventing new tumors.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: February 2, 2021
    Assignee: Immunopharma AS
    Inventors: Anne Berit Calmeyer Samuelsen, Lise Berven
  • Phytocannabinoid topical compositions for releiving pain
    Patent number: 10905730
    Abstract: A topical composition for pain relief comprising phytocannabinoids and a carrier vehicle for the phytocannabinoids, which include tetrahydrocannabinol THC and cannabidiol CBD present in amounts up to 25%, delivered to a user's skin and/or lips to alleviate pain.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: February 2, 2021
    Inventor: Agnes V. Mojsa
  • Methods for manufacturing and purifying dried burdock seed extract
    Patent number: 10898532
    Abstract: A method for manufacturing a dried burdock seed extract in order to manufacture the dried burdock seed extract rich in arcitigenin is disclosed. The method includes: sequentially mixing a raw material, water and an extractant to obtain a mixture. The mixture includes 7-14 vol % of the raw material, 8-40 vol % of water and 50-84 vol % of the extractant being a 95% aqueous ethanol solution. The raw material is then extracted at a boiling condition for 20-180 minutes, followed by concentration and centrifugation to obtain the dried burdock seed extract. A method for purifying the dried burdock seed extract is also disclosed.
    Type: Grant
    Filed: October 29, 2018
    Date of Patent: January 26, 2021
    Assignee: KANG LI BIOTECH CO., LTD.
    Inventors: Fu-An Chen, Chun-Che Sung, Chun Chen, Shih-Chiang Lee
  • Compositions for addressing physiological stresses and aging
    Patent number: 10881705
    Abstract: Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: January 5, 2021
    Assignee: 4Life Patents, LLC
    Inventor: Christopher M. Lockwood
  • Gut health compositions
    Patent number: 10881675
    Abstract: Gut health compositions include xylooligosaccharides (XOS) and a kiwifruit extract powder, which may include one or both of a) green kiwifruit extract powder having >7,500, and preferably >25,000, AUs/g actinidin, and optionally about 4.8 mg GAE total phenolics/600 mg and b) gold kiwifruit extract powder having >5,000 AUs/g actinidin and optionally about 6.6 mg GAE total phenolics/600 mg. Xylobiose, xylotriose and/or xylotetraose account for 50-98% by weight of the XOS.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: January 5, 2021
    Inventors: Jennifer L. Gu, Edward S. Lee
  • Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
    Patent number: 10874692
    Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as cognitive disorders. The methods relate to a regimen of pulsed dosing of blood plasma or blood plasma fractions.
    Type: Grant
    Filed: June 5, 2019
    Date of Patent: December 29, 2020
    Assignee: Alkahest, Inc.
    Inventors: Steven P. Braithwaite, Eva Czirr, Ian Gallager, Nina Huber, S. Sakura Minami
  • Topical cosmetic compositions
    Patent number: 10870022
    Abstract: Disclosed are compositions and methods for their use for reducing tumor necrosis factor alpha (TNF-?) and/or vascular endothelial growth factor (VEGF) production in skin cells by topically applying to skin in need thereof, a composition comprising an effective amount of Opuntia ficus-indica tuna, Opuntia ficus-indica nopales, or both, or extracts thereof, to reduce TNF-? or VEGF production in skin cells.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: December 22, 2020
    Assignee: Mary Kay Inc.
    Inventors: Michelle Hines, Geetha Kalahasti, Tiffany Florence, David Gan
  • Composition containing moringa extract and/or pulverized product
    Patent number: 10869829
    Abstract: A composition containing a Moringa extract and/or a Moringa pulverized product, wherein a mass ratio of a content of a moringin to a content of a glucomoringin (moringin/glucomoringin) is from 0.00005 to 0.30, and wherein a myrosinase is deactivated, or the composition does not contain a myrosinase. The composition of the present invention is useful in the fields of foodstuff, cosmetics, and the like.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: December 22, 2020
    Assignee: TAIYO KAGAKU CO., LTD.
    Inventors: Kazuo Shimizu, Masamitsu Moriwaki
  • Composition for preventing and/or treating cardiovascular and cerebrovascular diseases
    Patent number: 10857108
    Abstract: The present invention relates to a composition for preventing and/or treating cardiovascular and cerebrovascular diseases, a method for preparing the same, and use thereof, wherein the composition comprises at least two of docosahexaenoic acid or an ester thereof, coenzyme Q10, lipoic acid and phospholipid. The composition is used for preparing a dietary supplement or health food, preferably, for preparing a dietary supplement or health food for preventing and/or treating dyslipidemia or cardiovascular and cerebrovascular diseases.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: December 8, 2020
    Assignees: Xiamen Kingdomway Group Company, Xiamen Kingdomway Biotech. Co., Ltd.
    Inventors: Fangfang Chen, Weicheng Liao, Huaying Liu, Suxia Xu
  • Hybrid herbal and drug composition and method of formulation
    Patent number: 10857194
    Abstract: A hybrid herbal and drug composition includes an amount of Chinese herb about 0.01 to 5% by weight of the composition; an amount of animal-based matter about 0.01 to 5% by weight of the composition; an amount of vitamin about 0.01 to 5% by weight of the composition; an amount of mineral about 0.01 to 5% by weight of the composition; an amount of hormone about 0.01 to 5% by weight of the composition; an amount of factory produced product about 0.01 to 5% by weight of the composition; and an amount of the purified water about 70% to 99.94% by weight of the composition.
    Type: Grant
    Filed: February 14, 2019
    Date of Patent: December 8, 2020
    Inventor: Shui Yin Lo
  • Multivitamin capable of beneficial gene regulation through microRNA (MIRNA)
    Patent number: 10857124
    Abstract: The present invention includes compositions and methods for modifying the expression of microRNAs comprising: one or more plant secondary metabolites capable of beneficially regulating different genes in the human genome by modifying the expression of one or more microRNAs, wherein the one or more plant secondary metabolites are selected and provided in an amount selected to target the modification of one or more specific microRNA.
    Type: Grant
    Filed: August 21, 2019
    Date of Patent: December 8, 2020
    Assignee: PERFORMANCE LABS PTE. LTD.
    Inventor: Daniel Gubler
  • Essential element management
    Patent number: 10849949
    Abstract: The invention extends the utility of apparatus used to extract medicinal cannabis compounds into an eluate by separating a portion of medicinal cannabis compounds contained within a portion of eluate at a first extraction target level providing enough clean solvent to continue extraction operations. A high efficiency concentrator such as a rotary evaporator or a wiped film evaporator processes eluate from one or more tanks or extraction vessels creating clean solvent when extraction targets are met or when clean solvent is exhausted. This manages eluate concentration levels and limits the quantity of concentrated medicinal cannabis compounds on site at any moment in time. The invention enables a business model for keeping medicinal cannabis compounds within a legal system, and reduces pollution because law enforcement would no longer have to burn large quantities of cannabis plant matter.
    Type: Grant
    Filed: June 4, 2018
    Date of Patent: December 1, 2020
    Inventor: Robert J Rapp
  • Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
    Patent number: 10849951
    Abstract: The present invention includes a method of using PHY906 for treating a bowel disorder including inflammatory bowel disease and irritable bowel syndrome. Particularly, the present invention provides a multiple symptoms treatment for the bowel disorder.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: December 1, 2020
    Assignee: YALE UNIVERSITY
    Inventors: Yung-Chi Cheng, Shwu-Huey Liu, Robert Tilton
  • Placental tissue component compositions for treatment of skin defects and methods using same
    Patent number: 10849933
    Abstract: The present disclosure provides methods of treating defects such as wrinkles or scars via a subdermal injection of placental tissue components. It also provides placental tissue compositions maintained within the barrel of a syringe, which may be for use in treating such defects.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: December 1, 2020
    Assignee: MiMedx Group, Inc.
    Inventors: Rick LeVaughn, Sivakkumar Arjunon, Olivia Taylor
  • Compositions and methods for treating itching, gingivostomatitis, and demodectic mange
    Patent number: 10842819
    Abstract: Provided are methods for treating itching caused by allergy, include itching associated with parasite-mediated inflammation (e.g., demodicosis, stomatitis, dermatophytosis, etc.), comprising administration to a mammalian subject in need thereof a therapeutically effective amount of a heat-treated, fractionated thymus extract composition (e.g., Thyex-1-6A and -6B compositions, comprising proteins or polypeptides having molecular weights in the range of 3.5 kDa to 30 kDa), in combination with or formulated with colostrum, to provide for reducing itching in the subject. Combination or adjunctive therapies comprising administration of a heat-treated, fractionated thymus extract composition in combination with or formulated with colostrum, and including at least one additional anti-parasitic, anti-bacterial, anti-fungal, anti-viral agent, or homeopathic agent are also provided.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: November 24, 2020
    Assignee: CMI Research Management, LLC
    Inventors: Ryan Ushijima, Richard N. Ushijima
  • Composition and method of treating actinic purpura
    Patent number: 10842731
    Abstract: The present invention is a composition and method of treatment for actinic purpura, skin disorders, and skin conditions in general through topical systematic and periodic application of a formulation that generally may include ingredients to improve circulation such as but not limited to arnica oil CLR and phytotonine; ingredients to thicken the skin such as but not limited to retistar, glycolic acid, vitamin K1, and phyto-age; and ingredients to repair the skin's barrier, such as but not limited to timecode, SKINMIMICS, ABS pomegranate sterols, and pentatavitin.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: November 24, 2020
    Assignee: Clark Pharmaceuticals LLC
    Inventor: Stephen W. Clark
  • Decubitus treatment system
    Patent number: 10835569
    Abstract: The present invention includes compositions and methods for cleaning, treating, protection and resolution of decubitus ulcers comprising: a first composition comprising a wound cleaning solution comprising aloe vera gel comprising at least 5,000 MPS, a balanced salt solution; and a second composition comprising a wound healing gel comprising aloe vera gel comprising at least 10,000 MPS, a thickening agent, and one or more preservatives and, optionally, a third composition comprising a moisture barrier cream comprising a vegetable-based emulsifier, a cosmetic ester for dry skin that has low occlusivity, an ester-based emollient that is oxidation stable and has low occlusivity; a beeswax; a hydrogenated oil, glycerin, a buffering agent, aloe vera gel comprising at least 2,000 MPS and water.
    Type: Grant
    Filed: August 3, 2017
    Date of Patent: November 17, 2020
    Assignee: Aloe Bioscience, LLC
    Inventor: Ivan E. Danhof